Spatial Domain
Spatial Domain (Tier 1)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__87_A6,14 | Lung | Primary cancer | 3,661 | Tumor/Malignant | 67.1% | 0.98 | 0.11 |
| NSCLC_38242124__IMC__87_A6,15 | Lung | Primary cancer | 2,857 | Tumor/Malignant | 67.9% | 0.97 | 0.09 |
| NSCLC_38242124__IMC__87_A6,17 | Lung | Primary cancer | 2,087 | Tumor/Malignant | 39.7% | 0.73 | 0.63 |
| NSCLC_38242124__IMC__87_A6,2 | Lung | Primary cancer | 3,826 | Stromal | 38.7% | 0.38 | 1.02 |
| NSCLC_38242124__IMC__87_A6,3 | Lung | Primary cancer | 790 | Stromal | 34.7% | 0.49 | 0.83 |
| NSCLC_38242124__IMC__87_A6,4 | Lung | Primary cancer | 3,966 | Tumor/Malignant | 47.3% | 0.99 | 0.05 |
| NSCLC_38242124__IMC__87_A6,5 | Lung | Primary cancer | 3,071 | Stromal | 27.2% | 0.87 | 0.39 |
| NSCLC_38242124__IMC__87_A6,6 | Lung | Primary cancer | 951 | Stromal | 37.7% | 0.87 | 0.37 |
| NSCLC_38242124__IMC__87_A6,7 | Lung | Primary cancer | 2,781 | Immune | 30.0% | 0.87 | 0.36 |
| NSCLC_38242124__IMC__87_A6,8 | Lung | Primary cancer | 2,315 | Stromal | 32.7% | 0.76 | 0.62 |
| NSCLC_38242124__IMC__87_A6,9 | Lung | Primary cancer | 1,937 | Tumor/Malignant | 93.5% | 0.98 | 0.04 |
| NSCLC_38242124__IMC__87_A7,10 | Lung | Primary cancer | 2,605 | Tumor/Malignant | 87.0% | 0.97 | 0.07 |
| NSCLC_38242124__IMC__87_A7,12 | Lung | Primary cancer | 4,758 | Tumor/Malignant | 43.0% | 0.96 | 0.12 |
| NSCLC_38242124__IMC__87_A7,13 | Lung | Primary cancer | 4,151 | Immune | 54.9% | 0.91 | 0.25 |
| NSCLC_38242124__IMC__87_A7,14 | Lung | Primary cancer | 3,253 | Tumor/Malignant | 65.5% | 0.97 | 0.13 |
| NSCLC_38242124__IMC__87_A7,15 | Lung | Primary cancer | 2,902 | Tumor/Malignant | 46.1% | 0.95 | 0.16 |
| NSCLC_38242124__IMC__87_A7,16 | Lung | Primary cancer | 3,737 | Tumor/Malignant | 34.9% | 0.98 | 0.08 |
| NSCLC_38242124__IMC__87_A7,17 | Lung | Primary cancer | 3,487 | Tumor/Malignant | 67.2% | 0.97 | 0.12 |
| NSCLC_38242124__IMC__87_A7,2 | Lung | Primary cancer | 3,451 | Tumor/Malignant | 48.7% | 0.96 | 0.17 |
| NSCLC_38242124__IMC__87_A7,3 | Lung | Primary cancer | 1,637 | Tumor/Malignant | 49.2% | 0.93 | 0.23 |
Spatial Domain (Tier 2)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__87_A6,14 | Lung | Primary cancer | 3,661 | Tumor/Malignant | 57.5% | 0.99 | 0.05 |
| NSCLC_38242124__IMC__87_A6,15 | Lung | Primary cancer | 2,857 | Tumor/Malignant | 60.4% | 1.00 | 0.03 |
| NSCLC_38242124__IMC__87_A6,17 | Lung | Primary cancer | 2,087 | Tumor/Malignant | 44.2% | 0.95 | 0.21 |
| NSCLC_38242124__IMC__87_A6,2 | Lung | Primary cancer | 3,826 | Stromal | 31.2% | 0.39 | 1.09 |
| NSCLC_38242124__IMC__87_A6,3 | Lung | Primary cancer | 790 | Stromal | 30.1% | 0.55 | 0.86 |
| NSCLC_38242124__IMC__87_A6,4 | Lung | Primary cancer | 3,966 | Tumor/Malignant | 49.8% | 0.98 | 0.07 |
| NSCLC_38242124__IMC__87_A6,5 | Lung | Primary cancer | 3,071 | Stromal | 28.9% | 0.85 | 0.43 |
| NSCLC_38242124__IMC__87_A6,6 | Lung | Primary cancer | 951 | Stromal | 40.3% | 0.85 | 0.39 |
| NSCLC_38242124__IMC__87_A6,7 | Lung | Primary cancer | 2,781 | Lymphoid | 24.8% | 0.75 | 0.62 |
| NSCLC_38242124__IMC__87_A6,8 | Lung | Primary cancer | 2,315 | Stromal | 31.0% | 0.76 | 0.61 |
| NSCLC_38242124__IMC__87_A6,9 | Lung | Primary cancer | 1,937 | Tumor/Malignant | 68.5% | 0.99 | 0.02 |
| NSCLC_38242124__IMC__87_A7,10 | Lung | Primary cancer | 2,605 | Tumor/Malignant | 77.6% | 1.00 | 0.02 |
| NSCLC_38242124__IMC__87_A7,12 | Lung | Primary cancer | 4,758 | Tumor/Malignant | 42.5% | 0.96 | 0.12 |
| NSCLC_38242124__IMC__87_A7,13 | Lung | Primary cancer | 4,151 | Lymphoid | 35.7% | 0.76 | 0.60 |
| NSCLC_38242124__IMC__87_A7,14 | Lung | Primary cancer | 3,253 | Tumor/Malignant | 53.5% | 0.99 | 0.05 |
| NSCLC_38242124__IMC__87_A7,15 | Lung | Primary cancer | 2,902 | Tumor/Malignant | 45.5% | 0.96 | 0.15 |
| NSCLC_38242124__IMC__87_A7,16 | Lung | Primary cancer | 3,737 | Tumor/Malignant | 35.3% | 0.98 | 0.08 |
| NSCLC_38242124__IMC__87_A7,17 | Lung | Primary cancer | 3,487 | Tumor/Malignant | 52.8% | 0.97 | 0.10 |
| NSCLC_38242124__IMC__87_A7,2 | Lung | Primary cancer | 3,451 | Tumor/Malignant | 43.3% | 0.98 | 0.13 |
| NSCLC_38242124__IMC__87_A7,3 | Lung | Primary cancer | 1,637 | Tumor/Malignant | 46.7% | 0.93 | 0.21 |
Spatial Domain (Tier 3)
2,069 ready
| Sample | Organ | Disease state | Cells | Dominant compartment ?Largest Tier 1 spatial domain by sample fraction; this is a biological neighborhood label, not a row-count summary. | Domain share | Purity | Diversity |
|---|---|---|---|---|---|---|---|
| NSCLC_38242124__IMC__87_A6,14 | Lung | Primary cancer | 3,661 | Tumor/Malignant cell | 67.8% | 0.97 | 0.12 |
| NSCLC_38242124__IMC__87_A6,15 | Lung | Primary cancer | 2,857 | Tumor/Malignant cell | 68.1% | 0.97 | 0.09 |
| NSCLC_38242124__IMC__87_A6,17 | Lung | Primary cancer | 2,087 | Tumor/Malignant cell | 56.9% | 0.90 | 0.32 |
| NSCLC_38242124__IMC__87_A6,2 | Lung | Primary cancer | 3,826 | Fibroblast | 34.4% | 0.63 | 0.88 |
| NSCLC_38242124__IMC__87_A6,3 | Lung | Primary cancer | 790 | Fibroblast | 35.6% | 0.68 | 0.61 |
| NSCLC_38242124__IMC__87_A6,4 | Lung | Primary cancer | 3,966 | Tumor/Malignant cell | 54.5% | 0.96 | 0.13 |
| NSCLC_38242124__IMC__87_A6,5 | Lung | Primary cancer | 3,071 | Fibroblast | 40.0% | 0.77 | 0.56 |
| NSCLC_38242124__IMC__87_A6,6 | Lung | Primary cancer | 951 | Fibroblast | 36.9% | 0.85 | 0.42 |
| NSCLC_38242124__IMC__87_A6,7 | Lung | Primary cancer | 2,781 | T cell | 30.9% | 0.70 | 0.71 |
| NSCLC_38242124__IMC__87_A6,8 | Lung | Primary cancer | 2,315 | Fibroblast | 28.9% | 0.71 | 0.72 |
| NSCLC_38242124__IMC__87_A6,9 | Lung | Primary cancer | 1,937 | Tumor/Malignant cell | 93.5% | 0.98 | 0.04 |
| NSCLC_38242124__IMC__87_A7,10 | Lung | Primary cancer | 2,605 | Tumor/Malignant cell | 77.9% | 1.00 | 0.02 |
| NSCLC_38242124__IMC__87_A7,12 | Lung | Primary cancer | 4,758 | Tumor/Malignant cell | 43.8% | 0.95 | 0.15 |
| NSCLC_38242124__IMC__87_A7,13 | Lung | Primary cancer | 4,151 | T cell | 30.4% | 0.46 | 0.94 |
| NSCLC_38242124__IMC__87_A7,14 | Lung | Primary cancer | 3,253 | Tumor/Malignant cell | 65.6% | 0.97 | 0.14 |
| NSCLC_38242124__IMC__87_A7,15 | Lung | Primary cancer | 2,902 | Tumor/Malignant cell | 45.0% | 0.96 | 0.15 |
| NSCLC_38242124__IMC__87_A7,16 | Lung | Primary cancer | 3,737 | Tumor/Malignant cell | 35.3% | 0.98 | 0.09 |
| NSCLC_38242124__IMC__87_A7,17 | Lung | Primary cancer | 3,487 | Tumor/Malignant cell | 66.4% | 0.97 | 0.12 |
| NSCLC_38242124__IMC__87_A7,2 | Lung | Primary cancer | 3,451 | Tumor/Malignant cell | 48.7% | 0.97 | 0.17 |
| NSCLC_38242124__IMC__87_A7,3 | Lung | Primary cancer | 1,637 | Tumor/Malignant cell | 48.6% | 0.92 | 0.23 |